Ana Stancic, Director at IMMUNE PHARMACEUTICALS INC (IMNP), bought 8,000 shares at $2.50 ($20K) on 2014-11-26, disclosed to the SEC on 2014-12-03.
Open-market purchase of $20k IMNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.